Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
- PMID: 12196370
- DOI: 10.1093/annonc/mdf226
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
Abstract
Background: K-ras mutations, one of the earliest events observed in colorectal carcinogenesis, are mostly found in codons 12 and 13, and less frequently in codon 61, all three of which are estimated to be critical for the biological activity of the protein. Nevertheless the prognostic significance of such mutations remains controversial. Our purpose was to assess whether any or specific K-ras mutations in primary colorectal cancer had prognostic significance and were linked to clinico-pathological parameters.
Patients and methods: Paired tumor and normal tissue samples from a consecutive series of 160 untreated patients (median of follow up 71 months), undergoing resective surgery for primary colorectal carcinoma, were prospectively studied for K-ras mutations by PCR/single strand conformation polymorphism sequencing.
Results: Seventy-four of the 160 (46%) primary colorectal carcinomas presented mutations in K-ras: 54% in codon 12, 42% in codon 13 (particularly G-->A transition) and 4% in both. Codon 12 K-ras mutations were associated with mucinous histotype (P <0.01), while codon 13 K-ras mutations were associated with advanced Dukes' stage (P <0.05), lymph-node metastasis (P <0.05) and high S-phase fraction (P <0.05). Multivariate analysis showed that codon 13 K-ras mutations, but not any mutation, were independently related to risk of relapse or death.
Conclusions: Our results suggest that codon 12 K-ras mutations may have a role in the mucinous differentiation pathway, while codon 13 mutations have biological relevance in terms of colorectal cancer clinical outcome.
Similar articles
-
Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.Indian J Cancer. 2009 Jul-Sep;46(3):219-25. doi: 10.4103/0019-509X.52956. Indian J Cancer. 2009. PMID: 19574674
-
APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.Am Surg. 2005 Apr;71(4):336-43. Am Surg. 2005. PMID: 15943410
-
Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.Dis Colon Rectum. 2000 Feb;43(2):155-9; discussion 159-62. doi: 10.1007/BF02236973. Dis Colon Rectum. 2000. PMID: 10696887
-
K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.Int J Oncol. 2004 Jun;24(6):1537-44. Int J Oncol. 2004. PMID: 15138598
-
Is K-ras gene mutation a prognostic factor for colorectal cancer: a systematic review and meta-analysis.Dis Colon Rectum. 2012 Aug;55(8):913-23. doi: 10.1097/DCR.0b013e318251d8d9. Dis Colon Rectum. 2012. PMID: 22810479 Review.
Cited by
-
Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion.Mol Cancer. 2013 Jan 3;12:1. doi: 10.1186/1476-4598-12-1. Mol Cancer. 2013. PMID: 23286373 Free PMC article.
-
KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer.J Cancer Res Clin Oncol. 2013 Jun;139(6):953-61. doi: 10.1007/s00432-013-1401-9. Epub 2013 Mar 2. J Cancer Res Clin Oncol. 2013. PMID: 23455880
-
Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value.World J Gastroenterol. 2023 Aug 28;29(32):4883-4899. doi: 10.3748/wjg.v29.i32.4883. World J Gastroenterol. 2023. PMID: 37701134 Free PMC article.
-
The role of targeted therapy in the treatment of advanced colorectal cancer.Curr Treat Options Oncol. 2008 Dec;9(4-6):357-74. doi: 10.1007/s11864-009-0089-1. Epub 2009 Feb 24. Curr Treat Options Oncol. 2008. PMID: 19238551 Review.
-
Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in KRAS, and BRAFV600E in Patients with Lymph Node-Positive Colon Cancer.Curr Colorectal Cancer Rep. 2014 Sep 1;10(3):346-353. doi: 10.1007/s11888-014-0237-2. Curr Colorectal Cancer Rep. 2014. PMID: 25386108 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous